Open Access

Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma

  • Authors:
    • Jun Li
    • Junfei Jin
    • Minjun Liao
    • Wei Dang
    • Xinhuang Chen
    • Yongfeng Wu
    • Weijia Liao
  • View Affiliations

  • Published online on: January 25, 2018     https://doi.org/10.3892/ol.2018.7860
  • Pages: 4248-4254
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Previous cDNA microarray experiments revealed that the ATP‑dependent DNA helicase Q4 (RECQL4) gene is overexpressed in hepatocellular carcinoma (HCC) tissues. However, the exact role of RECQL4 in HCC remains unknown. The present study aimed to investigate RECQL4 expression in HCC and to analyze the potential clinical implications of RECQL4 expression in HCC patients. The expression of RECQL4 mRNA was assessed in 205 samples of HCC tissues by reverse transcription-quantitative polymerase chain reaction. The results demonstrated that the expression of RECQL4 mRNA in HCC tissues was significantly higher compared with adjacent normal liver tissues (P<0.001). The level of RECQL4 mRNA expression was associated with high a‑fetoprotein (AFP) levels (>100 ng/ml), tumor size (>6 cm), and Barcelona Clinic Liver Cancer stage (all P<0.05). Kaplan‑Meier survival analysis indicated that HCC patients with higher levels of RECQL4 expression exhibited significantly shorter disease‑free survival (DFS) and overall survival (OS) times compared with those with low levels of expression. Multivariate survival analysis revealed that high RECQL4 expression was a significant independent predictor for DFS [HR, 1.635; 95% confidence interval (CI), 1.062‑2.515; P=0.025] and OS (HR, 1.618; 95% CI, 1.050‑2.493; P=0.029) of HCC patients. These data indicated that RECQL4 might be a novel diagnostic and prognostic biomarker for HCC patients.

References

1 

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual. 6th. Springer; Chicago, IL: 2002, View Article : Google Scholar

3 

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 28:751–755. 1998. View Article : Google Scholar : PubMed/NCBI

4 

Llovet JM, Brú C and Bruix J: Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Liao W, Liu W, Yuan Q, Liu X, Ou Y, He S, Yuan S, Qin L, Chen Q, Nong K, et al: Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells. PLoS One. 8:e807892013. View Article : Google Scholar : PubMed/NCBI

6 

Liao W, Liu W, Liu X, Yuan Q, Ou Y, Qi Y, Huang W, Wang Y and Huang J: Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma. Oncotarget. 6:24132–24147. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Croteau DL, Singh DK, Hoh Ferrarelli L, Lu H and Bohr VA: RECQL4 in genomic instability and aging. Trends Genet. 28:624–631. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Petkovic M, Dietschy T, Freire R, Jiao R and Stagljar I: The human Rothmund-Thomson syndrome gene product, RECQL4, localizes to distinct nuclear foci that coincide with proteins involved in the maintenance of genome stability. J Cell Sci. 118:4261–4269. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Kitao S, Shimamoto A, Goto M, Miller RW, Smithson WA, Lindor NM and Furuichi Y: Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat Genet. 22:82–84. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Siitonen HA, Kopra O, Kääriäinen H, Haravuori H, Winter RM, Säämänen AM, Peltonen L and Kestilä M: Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases. Hum Mol Genet. 12:2837–2844. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Van Maldergem L, Siitonen HA, Jalkh N, Chouery E, De Roy M, Delague V, Muenke M, Jabs EW, Cai J, Wang LL, et al: Revisiting sis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. J Med Genet. 43:148–152. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Sangrithi MN, Bernal JA, Madine M, Philpott A, Lee J, Dunphy WG and Venkitaraman AR: Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome. Cell. 121:887–898. 2005. View Article : Google Scholar : PubMed/NCBI

14 

Xu X and Liu Y: Dual DNA unwinding activities of the Rothmund-Thomson syndrome protein, RECQ4. EMBO J. 28:568–577. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Collart C, Allen GE, Bradshaw CR, Smith JC and Zegerman P: Titration of four replication factors is essential for the Xenopus laevis midblastula transition. Science. 341:893–896. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Fan W and Luo J: RecQ4 facilitates UV light-induced DNA damage repair through interaction with nucleotide excision repair factor xeroderma pigmentosum group A (XPA). J Biol Chem. 283:29037–29044. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Schurman SH, Hedayati M, Wang Z, Singh DK, Speina E, Zhang Y, Becker K, Macris M, Sung P, Wilson DM III, et al: Direct and indirect roles of RECQL4 in modulating base excision repair capacity. Hum Mol Genet. 18:3470–3483. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Singh DK, Karmakar P, Aamann M, Schurman SH, May A, Croteau DL, Burks L, Plon SE and Bohr VA: The involvement of human RECQL4 in DNA double-strand break repair. Aging Cell. 9:358–371. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Maire G, Yoshimoto M, Chilton-MacNeill S, Thorner PS, Zielenska M and Squire JA: Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma. Neoplasia. 11:260–268. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Su Y, Meador JA, Calaf GM, Proietti De-Santis L, Zhao Y, Bohr VA and Balajee AS: Human RecQL4 helicase plays critical roles in prostate carcinogenesis. Cancer Res. 70:9207–9217. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Fang H, Nie L, Chi Z, Liu J, Guo D, Lu X, Hei TK, Balajee AS and Zhao Y: RecQL4 helicase amplification is involved in human breast tumorigenesis. PLoS One. 8:e696002013. View Article : Google Scholar : PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Zegerman P and Diffley JF: Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast. Nature. 445:281–285. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Xu X, Rochette PJ, Feyissa EA, Su TV and Liu Y: MCM10 mediates RECQ4 association with MCM2-7 helicase complex during DNA replication. EMBO J. 28:3005–3014. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Bruix J and Sherman M; American Association for the Study of Liver Diseases, : Management of hepatocellular carcinoma: An update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, et al: Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol. 12:364–373. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Kow AW, Kwon CH, Song S, Shin M, Kim JM and Joh JW: Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: Review of 1222 cases of hepatectomy in a tertiary institution. Ann Surg Oncol. 19:2246–2255. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N and Makuuchi M: Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 134:1908–1916. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Giannini EG, Farinati F, Ciccarese F, Pecorelli A, Rapaccini GL, Di Marco M, Benvegnù L, Caturelli E, Zoli M, Borzio F, et al: Prognosis of untreated hepatocellular carcinoma. Hepatology. 61:184–190. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Liu PH, Hsu CY, Hsia CY, Lee YH, Su CW, Huang YH, Lee FY, Lin HC and Huo TI: Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. J Hepatol. 64:601–608. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Gomaa AI, Hashim MS and Waked I: Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt. PLoS One. 9:e909292014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, J., Jin, J., Liao, M., Dang, W., Chen, X., Wu, Y., & Liao, W. (2018). Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma. Oncology Letters, 15, 4248-4254. https://doi.org/10.3892/ol.2018.7860
MLA
Li, J., Jin, J., Liao, M., Dang, W., Chen, X., Wu, Y., Liao, W."Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma". Oncology Letters 15.4 (2018): 4248-4254.
Chicago
Li, J., Jin, J., Liao, M., Dang, W., Chen, X., Wu, Y., Liao, W."Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma". Oncology Letters 15, no. 4 (2018): 4248-4254. https://doi.org/10.3892/ol.2018.7860